Literature DB >> 34083217

Renal Denervation for the Treatment of Hypertension: Unnerving or Underappreciated?

Harini Sarathy1, Jordana B Cohen2,3.   

Abstract

Entities:  

Keywords:  blood pressure; blood pressure management; hypertension; medication intolerance; medication nonadherence; renal denervation; sympathetic activity; treatment-resistant hypertension

Mesh：

Year:  2021        PMID： 34083217      PMCID： PMC8729587          DOI： 10.2215/CJN.03070221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  9 in total

1.  Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

Authors:  Felix Mahfoud; Michael Böhm; Michel Azizi; Atul Pathak; Isabelle Durand Zaleski; Sebastian Ewen; Kostantinos Tsioufis; Bert Andersson; Peter J Blankestijn; Michel Burnier; Gilles Chatellier; Sameer Gafoor; Guido Grassi; Michael Joner; Sverre E Kjeldsen; Thomas Felix Lüscher; Melvin D Lobo; Chaim Lotan; Gianfranco Parati; Josep Redon; Luis Ruilope; Isabella Sudano; Christian Ukena; Evert van Leeuwen; Massimo Volpe; Stephan Windecker; Adam Witkowski; William Wijns; Thomas Zeller; Roland E Schmieder
Journal:  Eur Heart J       Date:  2015-05-18       Impact factor: 29.983

2.  A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).

Authors:  Karl Fengler; Karl-Philipp Rommel; Stephan Blazek; Christian Besler; Philipp Hartung; Maximilian von Roeder; Martin Petzold; Sindy Winkler; Robert Höllriegel; Steffen Desch; Holger Thiele; Philipp Lurz
Journal:  Circulation       Date:  2019-01-29       Impact factor: 29.690

3.  A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.

Authors:  Laura Mauri; Kazuomi Kario; Jan Basile; Joost Daemen; Justin Davies; Ajay J Kirtane; Felix Mahfoud; Roland E Schmieder; Michael Weber; Shinsuke Nanto; Michel Azizi
Journal:  Am Heart J       Date:  2017-09-12       Impact factor: 4.749

Review 4.  The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.

Authors:  David E Kandzari; Kazuomi Kario; Felix Mahfoud; Sidney A Cohen; Garrett Pilcher; Stuart Pocock; Raymond Townsend; Michael A Weber; Michael Böhm
Journal:  Am Heart J       Date:  2015-09-11       Impact factor: 4.749

Review 5.  Translational medicine: the antihypertensive effect of renal denervation.

Authors:  Gerald F DiBona; Murray Esler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-02       Impact factor: 3.619

6.  Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.

Authors:  Michel Azizi; Roland E Schmieder; Felix Mahfoud; Michael A Weber; Joost Daemen; Melvin D Lobo; Andrew S P Sharp; Michael J Bloch; Jan Basile; Yale Wang; Manish Saxena; Philipp Lurz; Florian Rader; Jeremy Sayer; Naomi D L Fisher; David Fouassier; Neil C Barman; Helen Reeve-Stoffer; Candace McClure; Ajay J Kirtane
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

7.  Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.

Authors:  Michael Böhm; Kazuomi Kario; David E Kandzari; Felix Mahfoud; Michael A Weber; Roland E Schmieder; Konstantinos Tsioufis; Stuart Pocock; Dimitris Konstantinidis; James W Choi; Cara East; David P Lee; Adrian Ma; Sebastian Ewen; Debbie L Cohen; Robert Wilensky; Chandan M Devireddy; Janice Lea; Axel Schmid; Joachim Weil; Tolga Agdirlioglu; Denise Reedus; Brian K Jefferson; David Reyes; Richard D'Souza; Andrew S P Sharp; Faisal Sharif; Martin Fahy; Vanessa DeBruin; Sidney A Cohen; Sandeep Brar; Raymond R Townsend
Journal:  Lancet       Date:  2020-03-29       Impact factor: 79.321

8.  Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.

Authors:  David E Kandzari; Michael Böhm; Felix Mahfoud; Raymond R Townsend; Michael A Weber; Stuart Pocock; Konstantinos Tsioufis; Dimitrios Tousoulis; James W Choi; Cara East; Sandeep Brar; Sidney A Cohen; Martin Fahy; Garrett Pilcher; Kazuomi Kario
Journal:  Lancet       Date:  2018-05-23       Impact factor: 79.321

Review 9.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897
  9 in total
  1 in total

Review 1.  Advances in the Treatment Strategies in Hypertension: Present and Future.

Authors:  Paolo Verdecchia; Claudio Cavallini; Fabio Angeli
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.